|
1
|
de Rijk MC, Launer LJ, Berger K, Breteler
MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A,
Martinez-Lage J, Trenkwalder C and Hofman A: Prevalence of
Parkinson's disease in Europe: A collaborative study of
population-based cohorts. Neurology. 54(11 Suppl 5): S21–S23.
2000.PubMed/NCBI
|
|
2
|
Braak H, Del Tredici K, Rüb U, de Vos RA,
Jansen Steur EN and Braak E: Staging of brain pathology related to
sporadic Parkinson's disease. Neurobiol Aging. 24:197–211. 2003.
View Article : Google Scholar
|
|
3
|
Calne D: A definition of Parkinson's
disease. Parkinsonism Relat Disord. 11(Suppl 1): S39–S40. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hughes AJ, Daniel SE and Lees AJ: Improved
accuracy of clinical diagnosis of Lewy body Parkinson's disease.
Neurology. 57:1497–1499. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fitzmaurice AG, Rhodes SL, Lulla A, Murphy
NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M,
Sagasti A, et al: Aldehyde dehydrogenase inhibition as a pathogenic
mechanism in Parkinson disease. Proc Natl Acad Sci USA.
110:636–641. 2013. View Article : Google Scholar
|
|
6
|
Koutsilieri E, Scheller C, Grunblatt E,
Nara K, Li J and Riederer P: Free radicals in Parkinson's disease.
J Neurol. 249(Suppl 2): II1–II5. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Drechsel DA and Patel M: Role of reactive
oxygen species in the neurotoxicity of environmental agents
implicated in Parkinson's disease. Free Radic Biol Med.
44:1873–1886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goldstein DS, Sullivan P, Holmes C, Kopin
IJ, Basile MJ and Mash DC: Catechols in post-mortem brain of
patients with Parkinson disease. Eur J Neurol. 18:703–710. 2011.
View Article : Google Scholar
|
|
9
|
Singer TP and Ramsay RR: Mechanism of the
neurotoxicity of MPTP: An update. FEBS Lett. 274:1–8. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goping G, Pollard HB, Adeyemo OM and
Kuijpers GA: Effect of MPTP on dopaminergic neurons in the goldfish
brain: A light and electron microscope study. Brain Res. 687:35–52.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Connor T, Ireland LS, Harrison DJ and
Hayes JD: Major differences exist in the function and
tissue-specific expression of human B1 aldehyde reductase and the
principal human aldoketo reductase AKR1 family members. Biochem J.
343:487–504. 1999. View Article : Google Scholar
|
|
12
|
Esterbauer H, Schaur RJ and Zollner H:
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and
related aldehydes. Free Radic Biol Med. 11:81–128. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doorn JA and Petersen DR:
4-Hydroxynonenal-mediated inhibition of enzyme catalyzed oxidation
of the reactive electrophile 3,4-dihydroxyphenylacetaldehyde.
Toxicol Sci. 78:9802004.
|
|
14
|
Burke WJ, Li SW, Chung HD, Ruggiero DA,
Kristal BS, Johnson EM, Lampe P, Kumar VB, Franko M, Williams EA
and Zahm DS: Neurotoxicity of MAO metabolites of catechol-amine
neurotransmitters: Role in neurodegenerative diseases.
Neurotoxicol. 25:101–115. 2004. View Article : Google Scholar
|
|
15
|
Burke WJ, Li SW, Williams EA, Nonneman R
and Zahm DS: 3,4-Dihydroxyphenyl-acetaldehyde is the toxic dopamine
metabolite in vivo: Implications for Parkinson's disease
pathogenesis. Brain Res. 989:205–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Srivastava SK, Yadav UC, Reddy AB, Saxena
A, Tammali R, Shoeb M, Ansari NH, Bhatnagar A, Petrash MJ,
Srivastava S and Ramana KV: Aldose reductase inhibition suppresses
oxidative stress-induced inflammatory disorders. Chem Biol
Interact. 191:330–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lyon RC, Li D, McGarvie G and Ellis EM:
Aldo-keto reductases mediate constitutive and inducible protection
against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.
Neurochem Int. 62:113–121. 2013. View Article : Google Scholar
|
|
18
|
Pladzyk A, Ramana KV, Ansari NH and
Srivastava SK: Aldose reductase prevents aldehyde toxicity in
cultured human lens epithelial cells. Exp Eye Res. 83:408–416.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moon JI, Han MJ, Yu SH, Lee EH, Kim SM,
Han K, Park CH and Kim CH: Enhanced delivery of protein fused to
cell penetrating peptides to mammalian cells. BMB Rep. 52:324–329.
2019. View Article : Google Scholar :
|
|
20
|
van den Berg A and Dowdy SF: Protein
transduction domain delivery of therapeutic macromolecules. Curr
Opin Biotechnol. 22:888–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dietz GP: Cell-penetrating peptide
technology to deliver chaper-ones and associated factors in
diseases and basic research. Curr Pharm Biotechnol. 11:167–174.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gump JM and Dowdy SF: TAT transduction:
The molecular mechanism and therapeutic prospects. Trends Mol Med.
13:443–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim DW, Shin MJ, Choi YJ, Kwon HJ, Lee SH,
Lee S, Park J, Han KH, Eum WS and Choi SY: Tat-ATOX1 inhibits
inflamma-tory responses via regulation of MAPK and NF-κB pathways.
BMB Rep. 51:654–659. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shin MJ, Kim DW, Lee YP, Ahn EH, Jo HS,
Kim DS, Kwon OS, Kang TC, Cho YJ, Park J, et al: Tat-glyoxalase
protein inhibits against ischemic neuronal cell damage and
ameliorates ischemic injury. Free Radic Biol Med. 67:195–210. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shin MJ, Kim DW, Jo HS, Cho SB, Park JH,
Lee CH, Yeo EJ, Choi YJ, Kim JA, Hwang JS, et al: Tat-PRAS40
prevent hippo-campal HT-22 cell death and oxidative stress induced
animal brain ischemic insults. Free Radic Biol Med. 97:250–262.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeo HJ, Shin MJ, You JH, Kim JS, Kim MY,
Kim DW, Kim DS, Eum WS and Choi SY: Transduced Tat-CIAPIN1 reduces
the inflammatory response on LPS- and TPA-induced damages. BMB Rep.
52:695–699. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yeung PKK, Lai AKW, Son HJ, Zhang X, Hwang
O, Chung SSM and Chung SK: Aldose reductase deficiency leads to
oxidative stress-induced dopaminergic neuronal loss and autophagic
abnormality in an animal model of Parkinson's disease. Neurobiol
Aging. 50:119–133. 2017. View Article : Google Scholar
|
|
28
|
Cho SB, Eum WS, Shin MJ, Kwon HJ, Park JH,
Choi YJ, Park J, Han KH, Kang JH, Kim DS, et al: Transduced
Tat-aldose reductase protects hippocampal neuronal cells against
oxidative stress-induced damage. Exp Neurobiol. 28:612–627. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bradford M: A rapid and sensitive method
for the quantification of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han AR, Yang JW, Na JM, Choi SY and Cho
SW: Protective effects of N,4,5-trimethylthiazol-2-amine
hydrochloride on hypoxia-induced β-amyloid production in SH-SY5Y
cells. BMB Rep. 52:439–444. 2019. View Article : Google Scholar :
|
|
31
|
Ahn EH, Kim DW, Shin MJ, Kim YN, Kim HR,
Woo SJ, Kim SM, Kim DS, Kim J, Park J, et al: PEP-1-ribosomal
protein S3 protects dopaminergic neurons in an MPTP-induced
Parkinson's disease mouse model. Free Radic Biol Med. 55:36–45.
2013. View Article : Google Scholar
|
|
32
|
Kalivendi SV, Kotamraju S, Cunningham S,
Shang T, Hillard CJ and Kalyanaraman B: 1-methyl-4-phenylpyridinium
(MPP+)-induced apoptosis and mitochondrial oxidant
generation: Role of transferrin-receptor-dependent iron and
hydrogen peroxide. Biochem J. 371:151–164. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chongthammakun V, Sanvarinda Y and
Chongthammakun S: Reactive oxygen species production and MAPK
activation are implicated in tetrahydrobiopterin induced SH-SY5Y
cell death. Neurosci Lett. 449:178–182. 2009. View Article : Google Scholar
|
|
34
|
Zhu JH, Kulich SM, Oury TD and Chu CT:
Cytoplasmic aggre-gates of phosphorylated extracellular
signal-regulated protein kinases in Lewy body diseases. Am J
Pathol. 161:2087–2098. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Romuk EB, Szczurek W, Oles M, Gabrysiak A,
Skowron M, Nowak P and Birkner E: The evaluation of the changes in
enzy-matic antioxidant reserves and lipid peroxidation in chosen
parts of the brain in an animal model of Parkinson disease. Adv
Clin Exp Med. 26:953–959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang YL, Ju B, Zhang YZ, Yin HL, Liu YJ,
Wang SS, Zeng ZL, Yang XP, Wang HT and Li JF: Protective effect of
curcumin against oxidative stress-induced injury in rat with
Parkinson's disease through the Wnt/β-catenin signaling pathway.
Cell Physiol Biochem. 43:2226–2241. 2017. View Article : Google Scholar
|
|
37
|
Madamanchi NR, Vendrov A and Runge MS:
Oxidative stress and vascular disease. Arterioscler Thromb Vasc
Biol. 25:29–38. 2005. View Article : Google Scholar
|
|
38
|
Andersen JK: Oxidative stress in
neurodegeneration: Cause or consequence? Nat Med. 10:S18–S25. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cooke MS, Evans MD, Dizdaroglu M and Lunec
J: Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB
J. 17:1195–1214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang ES, Iwata K, Ikami K, Ham SA, Kim HJ,
Chang KC, Lee JH, Kim JH, Park SB, Km JH, et al: Aldose reductase
in kera-tinocytes attenuates cellular apoptosis and senescence
induced by UV radiation. Free Radic Biol Med. 50:680–688. 2011.
View Article : Google Scholar
|
|
41
|
Rittner HL, Hafner V, Klimiuk PA, Szweda
LI, Goronzy JJ and Weyand CM: Aldose reductase functions as a
detoxification system for lipid peroxidation products in
vasculitis. J Clin Invest. 103:1007–1013. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yabe-Nishimura C, Nishinaka T, Iwata K and
Seo HG: Up-regulation of aldose reductase by the substrate,
methyglyoxal. Chem Biol Interact. 143-144:317–323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang ES, Woo IS, Kim HJ, Eun SY, Paek KS,
Kim HJ, Chang KC, Lee JH, Lee HT, Kim JH, et al: Up-regulation of
aldose reductase expression mediated by phosphatidylinositol
3-kinase/Akt and Nrf2 is involved in the protective effect of
curcumin against oxidative stress. Free Radic Biol Med. 43:535–545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Camicioli R, Grossmann SJ, Spencer PS,
Hudnell K and Anger WK: Discriminating mild parkinsonism: Methods
for epidemiological research. Mov Disord. 16:33–40. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Park SW, Kim SH, Park KH, Kim SD, Kim JY,
Baek SY, Chung BS and Kang CD: Protective effect of antioxidants in
MPTP-induced mouse model of Parkinson's disease. Neurosci Lett.
363:243–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Goldstein DS, Sullivan P, Cooney A,
Jinsmaa Y, Sullivan R, Gross DJ, Holmes C, Kopin IJ and Sharabi Y:
Vesicular uptake blockade generates the toxic dopamine metabolite
3,4- dihydroxyphenylacetaldehyde in PC12 cells: Relevance to the
pathogenesis of Parkinson's disease. J Neurochem. 123:932–943.
2012. View Article : Google Scholar : PubMed/NCBI
|
